Veterinary & Aquaculture Infectious Disease Diagnostic Test Kits Market Size, Share & Trends Analysis by Product Type, Disease Type, End User, and Geography - Global Opportunity Analysis and Industry Forecast (2026-2036)

Description

List of Tables

According to the research report titled, 'Veterinary & Aquaculture Infectious Disease Diagnostic Test Kits Market Size, Share & Trends Analysis by Product Type (PCR/qPCR Kits, ELISA & Immunodiagnostic Kits, DNA/RNA Extraction Kits, Rapid Diagnostic Test Kits, LAMP Diagnostic Kits), Disease Type, End User, and Geography - Global Opportunity Analysis and Industry Forecast (2026-2036)' the global veterinary and aquaculture infectious disease diagnostic test kits market is projected to reach USD 10.47 billion by 2036, at a CAGR of 9.0% during the forecast period 2026-2036. The report provides an in-depth analysis of the global veterinary and aquaculture infectious disease diagnostic test kits market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036.

Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The growth of this market is driven by the rising incidence of transboundary and endemic animal diseases including African Swine Fever Virus (ASFV), Porcine Reproductive and Respiratory Syndrome (PRRS), White Spot Syndrome Virus (WSSV), Enterocytozoon hepatopenaei (EHP), and Acute Hepatopancreatic Necrosis Disease (AHPND), the rapid expansion of commercial swine and shrimp aquaculture production globally, and tightening export market biosecurity and food safety certification requirements. Moreover, growing government surveillance programs tied to WOAH disease notification obligations supporting diagnostic procurement, and the strong cost economics of early detection versus outbreak loss driving farmer and integrator adoption are expected to support the market's growth. However, laboratory infrastructure gaps and limited molecular diagnostic capacity restricting deployment in rural and provincial settings, cold chain requirements constraining field deployment of PCR-based diagnostic kits, and price sensitivity and budget constraints in public sector and smallholder farm procurement may restrain market growth.

The key players operating in the global veterinary and aquaculture infectious disease diagnostic test kits market are IDEXX Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), Neogen Corporation (U.S.), bioMerieux S.A. (France), Zoetis Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eiken Chemical Co., Ltd. (Japan), IDvet (Innovative Diagnostics) (France), Bionote, Inc. (South Korea), GeneReach Biotechnology Corp. (Taiwan), Gold Standard Diagnostics (U.S.), Indical Bioscience GmbH (Germany), Agrolabo S.p.A. (Italy), Creative Diagnostics (U.S.), and others.

The global veterinary and aquaculture infectious disease diagnostic test kits market is segmented by product type (PCR/qPCR diagnostic kits, ELISA & immunodiagnostic kits, DNA/RNA extraction kits, rapid diagnostic test kits, LAMP diagnostic kits, and other diagnostic kit types), disease type (swine diseases, shrimp diseases, and other veterinary & aquaculture infectious diseases), end user (commercial diagnostic laboratories, government & public veterinary laboratories, livestock producers and integrators, aquaculture producers, and research and academic institutions), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on product type, the PCR/qPCR diagnostic kits segment is expected to account for the largest share of the global veterinary and aquaculture infectious disease diagnostic test kits market in 2026. This segment leads mainly because of its established role as the reference standard for detecting major swine and shrimp pathogens including ASFV, PRRS, WSSV, EHP, and AHPND. PCR and qPCR platforms deliver high analytical sensitivity, greater specificity, and faster turnaround compared to conventional diagnostic methods, making them the preferred choice among government veterinary laboratories, commercial diagnostic laboratories, and large-scale integrated livestock and aquaculture producers globally. The extensive installed base of qPCR equipment across certified diagnostic facilities in North America, Europe, and Asia Pacific further reinforces this segment's dominant market position.

However, the LAMP diagnostic kits segment is projected to register the highest CAGR during the forecast period. The fast growth of this segment is mainly driven by the rising demand for decentralized molecular testing with minimal equipment requirements, which makes LAMP assays particularly well-suited for farm-level and hatchery-level rapid screening complementing centralized laboratory testing. LAMP platforms offer shorter turnaround times and lower infrastructure requirements compared to conventional PCR, enabling field veterinarians and commercial shrimp hatcheries operating with limited resources to conduct rapid on-site surveillance. Continued product innovation in portable and field-deployable LAMP kits targeting WSSV, EHP, AHPND, and ASFV is further accelerating the adoption of this segment globally.

Based on disease type, the swine diseases segment is expected to account for the largest share of the global veterinary and aquaculture infectious disease diagnostic test kits market in 2026. This segment's dominant position is attributed to the economic scale of the global pork industry, the high prevalence of economically devastating pathogens such as African Swine Fever Virus, PRRS, Porcine Epidemic Diarrhea Virus (PEDV), Classical Swine Fever, and Foot-and-Mouth Disease, and the well-established mandatory surveillance programs enforced by national veterinary authorities across major pork-producing regions including China, the European Union, Vietnam, and the United States. The recurring nature of ASFV and PRRS outbreaks creates a structurally large and consistent demand base for swine disease diagnostic kits globally.

Based on end user, the commercial diagnostic laboratories segment is expected to account for the largest share of the global veterinary and aquaculture infectious disease diagnostic test kits market in 2026. This segment's large share is primarily driven by the high testing volumes processed by centralized commercial laboratories serving integrated livestock producers, exporters, and veterinary clinics across major markets. Commercial laboratories offer rapid throughput, regulatory accreditation, and validated testing protocols for a broad panel of swine and aquaculture pathogens, making them the preferred outsourced diagnostic partner for large-scale farms, integrators, and shrimp exporters requiring certified test results for trade and biosecurity compliance. The expanding network of ISO-accredited commercial veterinary diagnostic laboratories across North America, Europe, and Asia Pacific further reinforces this segment's dominant position.

A thorough geographic analysis of the industry gives detailed insights into five major regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to account for the largest share of the global veterinary and aquaculture infectious disease diagnostic test kits market in 2026. This leading position is due to the well-established veterinary healthcare infrastructure, widespread adoption of advanced molecular diagnostic technologies including real-time qPCR as the reference standard across accredited government and commercial laboratories, and the strong regulatory framework governing veterinary diagnostic product quality and registration across the United States and Canada. The large scale of integrated swine and poultry production operations, combined with mandatory USDA disease surveillance and monitoring programs, creates a structurally high and consistent demand for diagnostic test kits in this region.

However, Asia Pacific is projected to register the highest CAGR during the forecast period. The fast growth of this region is driven by its large swine population and significant shrimp-producing countries including Vietnam, Thailand, India, Indonesia, and China, rising government investment in veterinary healthcare infrastructure and disease surveillance programs, and the growing adoption of molecular diagnostics to meet export market biosecurity and food safety certification requirements. The report includes a dedicated in-depth assessment of the Vietnam market, covering its swine and shrimp industries, disease epidemiology, diagnostic infrastructure, regulatory framework, pricing intelligence, and buyer procurement behavior.

Key Questions Answered in the Report-

What is the current revenue generated by the global veterinary and aquaculture infectious disease diagnostic test kits market?
At what rate is the global veterinary and aquaculture infectious disease diagnostic test kits market demand projected to grow for the next 5-10 years?
What are the historical market sizes and growth rates of the global veterinary and aquaculture infectious disease diagnostic test kits market?
What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
Which segments in terms of product type, disease type, and end user are expected to create major traction for the manufacturers in this market?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the manufacturers operating in the global veterinary and aquaculture infectious disease diagnostic test kits market?
Who are the major players in the global veterinary and aquaculture infectious disease diagnostic test kits market? What are their specific product offerings in this market?
What are the recent strategic developments in the global veterinary and aquaculture infectious disease diagnostic test kits market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Veterinary & Aquaculture Infectious Disease Diagnostic Test Kits Market Assessment - by Product Type

PCR/qPCR Diagnostic Kits
ELISA & Immunodiagnostic Kits
DNA/RNA Extraction Kits
Rapid Diagnostic Test Kits
LAMP Diagnostic Kits
Other Diagnostic Kit Types

Veterinary & Aquaculture Infectious Disease Diagnostic Test Kits Market Assessment - by Disease Type

Swine Diseases
- African Swine Fever Virus (ASFV)
- Porcine Reproductive and Respiratory Syndrome (PRRS)
- Porcine Epidemic Diarrhea Virus (PEDV)
- Classical Swine Fever (CSF)
- Foot-and-Mouth Disease (FMD)
- Other Swine Diseases
Shrimp Diseases
- White Spot Syndrome Virus (WSSV)
- Enterocytozoon hepatopenaei (EHP)
- Acute Hepatopancreatic Necrosis Disease (AHPND)
- Other Shrimp Diseases
Other Veterinary & Aquaculture Infectious Diseases

Veterinary & Aquaculture Infectious Disease Diagnostic Test Kits Market Assessment - by End User

Commercial Diagnostic Laboratories
Government & Public Veterinary Laboratories
Livestock Producers and Integrators
Aquaculture Producers
Research and Academic Institutions

Veterinary & Aquaculture Infectious Disease Diagnostic Test Kits Market Assessment - by Geography

North America
Europe
Asia-Pacific
Latin America
Middle East & Africa

Product Code: MRHC - 1042108

1. Market Definition & Scope

1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Data Collection & Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research
2.3. Market Assessment
- 2.3.1. Market Size Estimation
- 2.3.2. Bottom-Up Approach
- 2.3.3. Top-Down Approach
- 2.3.4. Growth Forecast
2.4. Assumptions For The Study

3. Executive Summary

4. Market Insights

4.1. Overview
4.2. Drivers
- 4.2.1. Rising Incidence of Asfv, Ehp, Wssv, Ahpnd, and Other Transboundary Animal Diseases Driving Surge In Diagnostic Kit Demand
- 4.2.2. Rapid Expansion of Commercial Swine and Shrimp/Aquaculture Production
- 4.2.3. Tightening Export Market Biosecurity and Food Safety Certification Requirements
- 4.2.4. Government Surveillance Programs and Woah Disease Notification Obligations Supporting Diagnostic Procurement
- 4.2.5. Cost Economics of Early Detection Vs. Outbreak Loss Driving Farmer and Integrator Adoption
4.3. Restraints
- 4.3.1. Laboratory Infrastructure Gaps and Limited Molecular Diagnostic Capacity Restricting Deployment in Rural and Provincial Settings
- 4.3.2. Cold Chain Requirements Constraining Field Deployment of Pcr-Based Diagnostic Kits
- 4.3.3. Price Sensitivity and Budget Constraints in Public Sector and Smallholder Farm Procurement
4.4. Opportunities
- 4.4.1. Lamp Technology Enabling Farm-Level and Hatchery-Level Rapid Molecular Testing Without Qpcr Equipment
- 4.4.2. Multiplex Kit Development Enabling Simultaneous Detection of Wssv, Ehp, Ahpnd, And Other Co-Infecting Pathogens
- 4.4.3. Emergence Of Next-Generation Technologies (Crispr-Based Diagnostics and Digital Pcr) Expanding Test Sensitivity and Accessibility
- 4.4.4. Expanding Vietnam Domestic Hatchery Certification and Spf Broodstock Programs Creating New High-Volume Testing Demand
4.5. Challenges
- 4.5.1. Regulatory Fragmentation and Divergent Kit Registration Requirements Across Vietnam, Southeast Asia, And Global Markets
- 4.5.2. Counterfeit And Unvalidated Diagnostic Products Eroding User Confidence in Market-Available Kits
- 4.5.3. Lack Of Trained Veterinary and Aquaculture Diagnostic Personnel for Advanced Molecular Testing Techniques
4.6. Trends
- 4.6.1. Shift From Conventional Pcr to Real-Time Qpcr as The Reference Standard for Asfv, Ehp, Wssv, And Ahpnd Detection
- 4.6.2. Growing Adoption of Lamp Kits for On-Farm and Hatchery Rapid Screening Complementing Centralized Laboratory Testing
- 4.6.3. Increasing Preference for Lyophilized and Room-Temperature-Stable Diagnostic Kits for Decentralized Veterinary and Aquaculture Testing
4.7. Regulatory Analysis
- 4.7.1. Vietnam: Ministry Of Agriculture and Environment (Mae) / Department of Animal Health (Dah) Diagnostic Kit Registration and Approval Framework
- 4.7.2. Woah Listed Disease Diagnostic Standards for Asfv, Wssv, Ahpnd, And Other Notifiable Disease
- 4.7.3. Southeast Asia: National Regulatory Frameworks for Veterinary Diagnostic Product Registration (Thailand, Indonesia, Philippines, Malaysia)
- 4.7.4. Global Regulatory Frameworks for Veterinary In-Vitro Diagnostic Products (United States, European Union, And Other Major Markets)
4.8. Porter's Five Forces Analysis
- 4.8.1. Threat Of New Entrants - Moderate
- 4.8.2. Bargaining Power of Suppliers - Moderate
- 4.8.3. Bargaining Power of Buyers - High
- 4.8.4. Threat Of Substitutes - Low to Moderate
- 4.8.5. Competitive Rivalry - High

5. Global Veterinary & Aquaculture Infectious Disease Diagnostic Test Kits Market - By Product Type

5.1. Overview
5.2. Pcr / Qpcr Diagnostic Kits
5.3. Elisa & Immunodiagnostic Kits
5.4. Dna/Rna Extraction Kits
5.5. Rapid Diagnostic Test Kits
5.6. Lamp Diagnostic Kits
5.7. Other Diagnostic Kit Types

6. Global Veterinary & Aquaculture Infectious Disease Diagnostic Test Kits Market - By Disease Type

6.1. Overview
6.2. Swine Diseases
6.3. African Swine Fever Virus (Asfv)
6.4. Porcine Reproductive and Respiratory Syndrome (Prrs)
6.5. Porcine Epidemic Diarrhea Virus (Pedv)
6.6. Classical Swine Fever (Csf)
6.7. Foot-And-Mouth Disease (Fmd)
6.8. Other Swine Diseases
6.9. Shrimp Diseases
6.10. White Spot Syndrome Virus (Wssv)
6.11. Enterocytozoon Hepatopenaei (Ehp)
6.12. Acute Hepatopancreatic Necrosis Disease (Ahpnd)
6.13. Other Shrimp Diseases
6.14. Other Veterinary & Aquaculture Infectious Diseases

7. Global Veterinary & Aquaculture Infectious Disease Diagnostic Test Kits Market - By End User

7.1. Overview
7.2. Commercial Diagnostic Laboratories
7.3. Government & Public Veterinary Laboratories
7.4. Livestock Producers and Integrators
7.5. Aquaculture Producers
7.6. Research And Academic Institutions

8. Global Veterinary & Aquaculture Infectious Disease Diagnostic Test Kits Market - By Geography

8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia-Pacific
- 8.4.1. Vietnam
  - 8.4.1.1. Swine Sector Overview
  - 8.4.1.2. Shrimp/Aquaculture Sector Overview
  - 8.4.1.3. Vietnam Disease Situation
  - 8.4.1.4. Diagnostic Testing Infrastructure
    - 8.4.1.4.1. Vietnam Diagnostic Testing Infrastructure Overview
    - 8.4.1.4.2. Market Implications
  - 8.4.1.5. Regulatory And Registration Framework - Mard/Dah Approval Process and Approved Kit List
    - 8.4.1.5.1. Overview
    - 8.4.1.5.2. Vietnam Veterinary Diagnostic Kit Registration Process
    - 8.4.1.5.3. Approved Kit List
    - 8.4.1.5.4. Market Implications
  - 8.4.1.6. Pricing Intelligence - Pcr, Lamp, Rapid Test, And Extraction Kit Pricing Analysis
  - 8.4.1.7. Buyer Ecosystem And Procurement Behavior
    - 8.4.1.7.1. Buyer Ecosystem Overview
    - 8.4.1.7.2. Procurement Decision Matrix
    - 8.4.1.7.3. Technology Adoption Preferences, By Buyer Category
8.5. Latin America
8.6. Middle East & Africa

9. Competitive Landscape

9.1. Introduction
9.2. Competitive Benchmarking
9.3. Competitive Dashboard
9.4. Industry Leaders
9.5. Market Differentiators
9.6. Vanguards
9.7. Emerging Companies
9.8. Market Share/Position Analysis

10. Company Profiles

10.1. Thermo Fisher Scientific Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Overview
- 10.1.3. Product Portfolio
- 10.1.4. Swot Analysis
10.2. IDEXX Laboratories, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Overview
- 10.2.3. Product Portfolio
- 10.2.4. Swot Analysis
10.3. Biomerieux S.A.
- 10.3.1. Company Overview
- 10.3.2. Financial Overview
- 10.3.3. Product Portfolio
- 10.3.4. Strategic Developments
- 10.3.5. Swot Analysis
10.4. IDvet (Innovative Diagnostics)
- 10.4.1. Company Overview
- 10.4.2. Product Portfolio
10.5. Zoetis Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Overview
- 10.5.3. Product Portfolio
- 10.5.4. Strategic Developments
10.6. Qiagen N.V.
- 10.6.1. Company Overview
- 10.6.2. Financial Overview
- 10.6.3. Product Portfolio
- 10.6.4. Strategic Developments
10.7. Gold Standard Diagnostics
- 10.7.1. Company Overview
- 10.7.2. Product Portfolio
10.8. Bionote, Inc.
- 10.8.1. Company Overview
- 10.8.2. Product Portfolio
- 10.8.3. Strategic Developments
10.9. Neogen Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Overview
- 10.9.3. Product Portfolio
10.10. Genereach Biotechnology Corp.
- 10.10.1. Company Overview
- 10.10.2. Product Portfolio
10.11. Eiken Chemical Co., Ltd.
- 10.11.1. Company Overview
- 10.11.2. Financial Overview
- 10.11.3. Product Portfolio
10.12. Bio-Rad Laboratories, Inc.
- 10.12.1. Company Overview
- 10.12.2. Financial Overview
- 10.12.3. Product Portfolio
10.13. Indical Bioscience GmbH
- 10.13.1. Company Overview
- 10.13.2. Product Portfolio
10.14. Agrolabo S.P.A.
- 10.14.1. Company Overview
- 10.14.2. Product Portfolio
10.15. Creative Diagnostics
- 10.15.1. Company Overview
- 10.15.2. Product Portfolio

11. Appendix

11.1. Available Customization
11.2. Related Reports